{"DataElement":{"publicId":"2188799","version":"1","preferredName":"Adverse Event Directed Measure Name","preferredDefinition":"Type of action taken in response to an unwanted effect caused by a drug or therapy. Such effects can be drug related, dose related, route related, patient related, caused by an interaction with another drug, or caused by opioid initiation or dose escalation.","longName":"AE_DIR_MSR_NM","context":"SPOREs","contextVersion":"2.31","DataElementConcept":{"publicId":"2013054","version":"3","preferredName":"Adverse Event Action","preferredDefinition":"Action taken in response to an unwanted effect caused by a drug or therapy. Such effects can be drug related, dose related, route related, patient related, caused by an interaction with another drug, or caused by opioid initiation or dose escalation.","longName":"AE_ACTION","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2184272","version":"1","preferredName":"Adverse Event","preferredDefinition":"An unwanted effect caused by a drug or therapy.  Such effects can be drug related, dose related, route related, patient related, caused by an interaction with another drug, or caused by opioid initiation or dose escalation.","longName":"Adverse Event","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-194E-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":"Change concept code to C41331 as C2861 is retired per EVS. dw","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2183650","version":"1","preferredName":"Action","preferredDefinition":"a thing done.","longName":"Action","context":"CCR","contextVersion":"1","Concepts":[{"longName":"Action","conceptCode":"C25404","definition":"A thing done.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9AFFD26-23B2-08E4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-07","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008573","version":"1","preferredName":"Adverse Event Results","preferredDefinition":"the outcome or resolution of the patient's adverse events.","longName":"AE_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB869948-5E78-2537-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-04-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-04-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7BA4F51-3E42-45B9-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-08","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-08","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2188761","version":"1","preferredName":"Adverse Event Directed MeasureType","preferredDefinition":"Activities and measures instituted for a patient/participant in response to an adverse event.","longName":"AE_DIR_MSR_TP","context":"SPOREs","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"40","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"AE-Directed Measures","valueDescription":"Adverse Event Directed Measures","ValueMeaning":{"publicId":"2571992","version":"1","preferredName":"Adverse Event Directed Measures","longName":"2571992","preferredDefinition":"Any unfavorable or unintended symptom, sign, or disease including an abnormal laboratory finding) temporally associated with the use of a medical treatment or procedure that may or may not be considered related to the medical treatment or procedure.  Such events can be intervention related, dose related, route related, patient related, or caused by an interaction with another drug(s) or procedure(s).: Joined in some kind of relationship.: A thing done.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Associated","conceptCode":"C25281","definition":"Joined in some kind of relationship.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Action","conceptCode":"C25404","definition":"A thing done.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E645-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-09-30","modifiedBy":"REEVESD","dateModified":"2014-09-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E49C180D-8C36-0916-E034-0003BA3F9857","beginDate":"2004-10-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-10-01","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Medications","valueDescription":"Medications for Adverse Event","ValueMeaning":{"publicId":"2571993","version":"1","preferredName":"Medications for Adverse Event","longName":"2571993","preferredDefinition":"Any unfavorable or unintended symptom, sign, or disease including an abnormal laboratory finding) temporally associated with the use of a medical treatment or procedure that may or may not be considered related to the medical treatment or procedure.  Such events can be intervention related, dose related, route related, patient related, or caused by an interaction with another drug(s) or procedure(s).: A pharmaceutical agent other than agent(s) tested in a given protocol that is administered to or used by a subject either prior to or during the study. Supportive care and essential ancillary medications required by a treatment regimen should be clearly identified. A protocol complete instructions including appropriate indication, dosage, administration route, schedule, restrictions to use, and any other relevant data should be explicitly stated. Concept also refers to substance(s) used prior or during the study that are not specified by the protocol.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Concomitant Agent","conceptCode":"C70902","definition":"A pharmaceutical agent other than agent(s) tested in a given protocol that is administered to or used by a subject either prior to or during the study. Supportive care and essential ancillary medications required by a treatment regimen should be clearly identified. A protocol's complete instructions including appropriate indication, dosage, administration route, schedule, restrictions to use, and any other relevant data should be explicitly stated. Concept also refers to substance(s) used prior or during the study that are not specified by the protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E646-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-09-30","modifiedBy":"REEVESD","dateModified":"2014-09-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E49C180D-8C37-0916-E034-0003BA3F9857","beginDate":"2004-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-10-01","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Hospitalization","valueDescription":"Hospitalization for AE","ValueMeaning":{"publicId":"2571994","version":"1","preferredName":"Hospitalization for AE","longName":"2571994","preferredDefinition":"An indication or description that an adverse event is associated with or prolongs hospitalization.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adverse Event associated with Hospitalization","conceptCode":"C83052","definition":"An indication or description that an adverse event is associated with or prolongs hospitalization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E647-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-09-30","modifiedBy":"REEVESD","dateModified":"2014-09-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E49C180D-8C38-0916-E034-0003BA3F9857","beginDate":"2004-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-10-01","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"None","valueDescription":"No AE Measures","ValueMeaning":{"publicId":"2571995","version":"1","preferredName":"No AE Measures","longName":"2571995","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E648-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-09-30","modifiedBy":"REEVESD","dateModified":"2014-09-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E49C180D-8C3E-0916-E034-0003BA3F9857","beginDate":"2004-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-10-01","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Dose Reduced","valueDescription":"Dose Reduced","ValueMeaning":{"publicId":"2562123","version":"1","preferredName":"Dose Reduced","longName":"2562123","preferredDefinition":"An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dose Reduced","conceptCode":"C49505","definition":"An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-BFB8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-07-22","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-07-22","modifiedBy":"KUMMEROA","dateModified":"2023-03-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E49C180D-8C3F-0916-E034-0003BA3F9857","beginDate":"2004-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-10-01","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Regimen Interrupted","valueDescription":"Regimen Interrupted","ValueMeaning":{"publicId":"2562302","version":"1","preferredName":"Regimen Interrupted","longName":"2562302","preferredDefinition":"A treatment plan that specifies the dosage, the schedule, and the duration of treatment.: A time interval during which there is a temporary cessation of something.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Treatment Regimen","conceptCode":"C15697","definition":"A treatment plan that specifies the dosage, the schedule, and the duration of treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Interruption","conceptCode":"C25542","definition":"A time interval during which there is a temporary cessation of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C06B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-08","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-08","modifiedBy":"REEVESD","dateModified":"2014-09-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E49C180D-8C40-0916-E034-0003BA3F9857","beginDate":"2004-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-10-01","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Therapy Discontinued","valueDescription":"Therapy Discontinued","ValueMeaning":{"publicId":"2570745","version":"1","preferredName":"Therapy Discontinued","longName":"2570745","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.: To stop or end, permanently or temporarily.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Discontinue","conceptCode":"C25484","definition":"To stop or end, permanently or temporarily.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E166-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"REEVESD","dateModified":"2014-09-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E49C180D-8C41-0916-E034-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-10-01","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Interrupted and Reduced","valueDescription":"Interrupted and Reduced","ValueMeaning":{"publicId":"2571997","version":"1","preferredName":"Interrupted and Reduced","longName":"2571997","preferredDefinition":"An indication that a medication schedule was modified by temporarily terminating a prescribed regimen of medication.: An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Drug Interrupted","conceptCode":"C49501","definition":"An indication that a medication schedule was modified by temporarily terminating a prescribed regimen of medication.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dose Reduced","conceptCode":"C49505","definition":"An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E64A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-10-01","modifiedBy":"REEVESD","dateModified":"2014-09-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E49C180D-8C43-0916-E034-0003BA3F9857","beginDate":"2004-10-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-10-01","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Medication and non-drug Therapy","valueDescription":"Medication And Negation Pharmacologic Substance Therapeutic Procedure","ValueMeaning":{"publicId":"4487653","version":"1","preferredName":"Medication And Negation Pharmacologic Substance Therapeutic Procedure","longName":"4487653","preferredDefinition":"A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: An operation in which a term denies or inverts the meaning of another term or construction.: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.: An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medication","conceptCode":"C459","definition":"A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pharmacologic Substance","conceptCode":"C1909","definition":"Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"036E0475-08A8-FC13-E050-BB89AD43033C","latestVersionIndicator":"Yes","beginDate":"2014-09-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-09-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"036E0475-08C1-FC13-E050-BB89AD43033C","beginDate":"2014-09-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-09-19","modifiedBy":"ONEDATA","dateModified":"2014-09-19","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"036E0475-08CB-FC13-E050-BB89AD43033C","beginDate":"2014-09-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-09-19","modifiedBy":"ONEDATA","dateModified":"2014-09-19","deletedIndicator":"No"},{"value":"Non-drug Therapy","valueDescription":"Non-drug Therapy","ValueMeaning":{"publicId":"2959505","version":"1","preferredName":"Non-drug Therapy","longName":"2959505","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.: An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pharmacologic Substance","conceptCode":"C1909","definition":"Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77FB3FCA-A074-A978-E040-BB89AD435145","latestVersionIndicator":"Yes","beginDate":"2009-11-09","endDate":null,"createdBy":"UMLLOADER_COPPAPRD","dateCreated":"2009-11-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"036E0475-08DF-FC13-E050-BB89AD43033C","beginDate":"2014-09-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-09-19","modifiedBy":"ONEDATA","dateModified":"2014-09-19","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E49C17FE-4D2C-0918-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-09-30","modifiedBy":"REEVESD","dateModified":"2014-09-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[{"name":"ENGLISH","type":"CONTEXT NAME","context":"SPOREs"},{"name":"ECOG-ACRIN","type":"USED_BY","context":"ECOG-ACRIN"}],"ReferenceDocuments":[{"name":"Adverse Event Action","type":"Preferred Question Text","description":"Adverse Event Action","url":null,"context":"SPOREs"},{"name":"ECOG CRF Text 1","type":"Alternate Question Text","description":"Other Action taken","url":null,"context":"ECOG-ACRIN"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E49C17FE-4D66-0918-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-10-01","modifiedBy":"ROUILLAS","dateModified":"2014-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}